ADMINISTERING
MEDICATIONS: 2025 RELEASE
• AUTHOR(S)DONNA
GAUWITZ
TEST BANK
1
Reference
Ch. 1 — Definition of Terms / Pharmacology
Stem
A 72-year-old man is admitted with newly diagnosed atrial
fibrillation. His provider orders warfarin 5 mg PO nightly. The
patient asks you what "anticoagulant" means and is worried
about bleeding. As the nurse, which response best integrates
,pharmacology definitions and immediate safety teaching while
promoting medication adherence?
A. “An anticoagulant is the same as a blood thinner; take it at
night and avoid all exercise.”
B. “An anticoagulant reduces clotting; I’ll teach you signs of
bleeding and explain monitoring like INR.”
C. “It prevents clots by dissolving current clots; you must stop if
you see any bruises.”
D. “It’s a medicine to make your blood thicker so clots won’t
form; call if you feel lightheaded.”
Correct answer: B
Rationale — Correct (B)
This answer accurately defines the drug class (reduces clotting),
includes immediate safety teaching (signs of bleeding), and
mentions required monitoring (INR), aligning with
pharmacology principles and promoting informed adherence. It
balances accurate information and actionable patient
education.
Rationale — Incorrect
A: Incorrect terminology (“same as blood thinner” is colloquial)
and unsafe instruction to avoid all exercise; not evidence-based.
C: Incorrect pharmacologic mechanism (warfarin does not
dissolve clots) and unsafe directive to stop medication without
provider guidance.
D: Incorrect mechanism (warfarin does not thicken blood);
vague advice that could confuse the patient.
,Teaching Point
Define class, teach bleeding signs, and explain monitoring
requirements.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
2
Reference
Ch. 1 — Drug Sources / Drug Standards
Stem
A staff nurse preparing medications notes a new injectable
antibiotic with a label indicating it is produced from a
recombinant DNA source. Which nursing interpretation and
immediate action best reflect safe medication administration
principles?
A. Assume it’s experimental and refuse to administer until the
manufacturer confirms safety.
B. Recognize it as a biologic; verify the drug against the
prescriber’s order and institutional formulary before
administering.
C. Treat it as interchangeable with small-molecule antibiotics
and proceed without extra verification.
D. Ask the patient whether they consent to "recombinant"
products and withhold if unsure.
Correct answer: B
, Rationale — Correct (B)
Recognizing biologics and verifying against the order and
formulary follows drug standard and source knowledge;
verification minimizes administration errors and aligns with
institutional safety procedures.
Rationale — Incorrect
A: Overly cautious and impractical—refusal without consulting
policy or prescriber is inappropriate.
C: Unsafe—biologics often have different handling and
substitution rules; treating them as interchangeable risks errors.
D: While informed consent is important, the immediate priority
is verification with prescriber/formulary; patient consent
discussion is secondary.
Teaching Point
Verify biologics against the order and formulary before
administration.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
3
Reference
Ch. 1 — Drug Names / Brand-Name vs Generic-Name Drugs
Stem
A busy med-surg unit receives two boxes labeled
“acetaminophen 500 mg — Brand A” and “paracetamol 500 mg
MEDICATIONS: 2025 RELEASE
• AUTHOR(S)DONNA
GAUWITZ
TEST BANK
1
Reference
Ch. 1 — Definition of Terms / Pharmacology
Stem
A 72-year-old man is admitted with newly diagnosed atrial
fibrillation. His provider orders warfarin 5 mg PO nightly. The
patient asks you what "anticoagulant" means and is worried
about bleeding. As the nurse, which response best integrates
,pharmacology definitions and immediate safety teaching while
promoting medication adherence?
A. “An anticoagulant is the same as a blood thinner; take it at
night and avoid all exercise.”
B. “An anticoagulant reduces clotting; I’ll teach you signs of
bleeding and explain monitoring like INR.”
C. “It prevents clots by dissolving current clots; you must stop if
you see any bruises.”
D. “It’s a medicine to make your blood thicker so clots won’t
form; call if you feel lightheaded.”
Correct answer: B
Rationale — Correct (B)
This answer accurately defines the drug class (reduces clotting),
includes immediate safety teaching (signs of bleeding), and
mentions required monitoring (INR), aligning with
pharmacology principles and promoting informed adherence. It
balances accurate information and actionable patient
education.
Rationale — Incorrect
A: Incorrect terminology (“same as blood thinner” is colloquial)
and unsafe instruction to avoid all exercise; not evidence-based.
C: Incorrect pharmacologic mechanism (warfarin does not
dissolve clots) and unsafe directive to stop medication without
provider guidance.
D: Incorrect mechanism (warfarin does not thicken blood);
vague advice that could confuse the patient.
,Teaching Point
Define class, teach bleeding signs, and explain monitoring
requirements.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
2
Reference
Ch. 1 — Drug Sources / Drug Standards
Stem
A staff nurse preparing medications notes a new injectable
antibiotic with a label indicating it is produced from a
recombinant DNA source. Which nursing interpretation and
immediate action best reflect safe medication administration
principles?
A. Assume it’s experimental and refuse to administer until the
manufacturer confirms safety.
B. Recognize it as a biologic; verify the drug against the
prescriber’s order and institutional formulary before
administering.
C. Treat it as interchangeable with small-molecule antibiotics
and proceed without extra verification.
D. Ask the patient whether they consent to "recombinant"
products and withhold if unsure.
Correct answer: B
, Rationale — Correct (B)
Recognizing biologics and verifying against the order and
formulary follows drug standard and source knowledge;
verification minimizes administration errors and aligns with
institutional safety procedures.
Rationale — Incorrect
A: Overly cautious and impractical—refusal without consulting
policy or prescriber is inappropriate.
C: Unsafe—biologics often have different handling and
substitution rules; treating them as interchangeable risks errors.
D: While informed consent is important, the immediate priority
is verification with prescriber/formulary; patient consent
discussion is secondary.
Teaching Point
Verify biologics against the order and formulary before
administration.
Citation
Gauwitz, D. (2025). Administering Medications. Ch. 1.
3
Reference
Ch. 1 — Drug Names / Brand-Name vs Generic-Name Drugs
Stem
A busy med-surg unit receives two boxes labeled
“acetaminophen 500 mg — Brand A” and “paracetamol 500 mg
